We update our database every week.Sign up for an account to receive new information about trials and treatments.
Since last update
@UCSF PDL1 CTLA4 double positive predicts response to anti–PD-1 therapy in #Melanoma #TRICON #immunotherapy https://t.co/m4TadSDWH3
@MolecularMatch CEO @jkevincoker tied for 1st. @LindsayDeneault was MM intern= total domination. #guac-sweep! https://t.co/z08xhyXgav
Judging @TMCInnovation #guacoff. Feels like some cooking going on already! https://t.co/e1AzfXL38V